End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
32.77 CNY | +0.06% | +4.03% | -20.96% |
25/04 | Huadong Medicine Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
18/04 | Huadong Medicine's 2023 Profit Jumps 14% | MT |
Business Summary
Number of employees: 16,969
Sales per Business
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Business
67.7
%
| 25,601 | 67.9 % | 27,495 | 67.7 % | +7.40% |
Manufacturing
30.0
%
| 11,347 | 30.1 % | 12,203 | 30.0 % | +7.54% |
International Medical Beauty
5.4
%
| 1,664 | 4.4 % | 2,192 | 5.4 % | +31.71% |
Inter-segment Elimination
-4.0
%
| -1,124 | -3.0 % | -1,629 | -4.0 % | +44.97% |
Other Business
0.9
%
| 226 | 0.6 % | 362 | 0.9 % | +60.37% |
Sales per region
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
96.5
%
| 36,549 | 96.9 % | 39,197 | 96.5 % | +7.24% |
International
3.5
%
| 1,165 | 3.1 % | 1,427 | 3.5 % | +22.49% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Hong Lan Ma
DFI | Director of Finance/CFO | 53 | - |
Bang Liang Li
CHM | Chairman | 78 | 01/72/01 |
Dong Zhou Liu
CTO | Chief Tech/Sci/R&D Officer | - | - |
Li Hong Xie
IRC | Investor Relations Contact | - | - |
Bo Chen
SEC | Corporate Secretary | 52 | 12/10/12 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Bang Liang Li
CHM | Chairman | 78 | 01/72/01 |
Wei Kang
BRD | Director/Board Member | 56 | - |
Liang Lü
CEO | Chief Executive Officer | 50 | 01/10/01 |
Hang Fu
BRD | Director/Board Member | 60 | - |
Yun Qin
BRD | Director/Board Member | 54 | 01/06/01 |
Ling Min Shao
BRD | Director/Board Member | 62 | 01/81/01 |
Lan Yang
BRD | Director/Board Member | 55 | - |
Xiao Ming Zhong
BRD | Director/Board Member | 62 | - |
Liang Zhu
BRD | Director/Board Member | 47 | - |
Yi Mei Wu
BRD | Director/Board Member | 60 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,754,327,548 | 734,399,391 ( 41.86 %) | 4,615,800 ( 0.2631 %) | 41.86 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
HEIDELBERG PHARMA AG 34.99% | 16,304,560 | 34.99% | 54,939,845 $ |
Company contact information
Sector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.96% | 7.91B | |
+17.35% | 71.39B | |
+2.39% | 25.1B | |
+5.38% | 8.59B | |
+6.69% | 8.19B | |
+0.49% | 4.54B | |
+17.12% | 4.31B | |
-3.38% | 3.93B | |
-2.61% | 3.86B | |
+22.08% | 3.64B |
- Stock Market
- Equities
- 000963 Stock
- Company Huadong Medicine Co., Ltd